UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

Journal of Crohn's and colitis, 2017-06, Vol.11 (6), p.649-670

2017

Volltextzugriff (PDF)

Differential diagnosis of inflammatory bowel disease: imitations and complications

The lancet. Gastroenterology & hepatology, 2018-09, Vol.3 (9), p.644-653

2018

Volltextzugriff (PDF)

A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease

Gut, 2014-09, Vol.63 (9), p.1381-1392

2014

Volltextzugriff (PDF)

Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients

Scandinavian journal of gastroenterology, 2019-04, Vol.54 (4), p.453-458

2019

Volltextzugriff (PDF)

Impact of disease location on fecal calprotectin levels in Crohn's disease

Scandinavian journal of gastroenterology, 2015-07, Vol.50 (7), p.841-847

2015

Volltextzugriff (PDF)

High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study

Inflammatory bowel diseases, 2021-03, Vol.27 (3), p.352-363

2021

Volltextzugriff (PDF)

Biosimilars for the Management of Inflammatory Bowel Diseases: Economic Considerations

Current medicinal chemistry, 2019-01, Vol.26 (2), p.259

2019

Volltextzugriff (PDF)

Relapse rates and predictors for relapse in a real-life cohort of IBD patients after discontinuation of anti-TNF therapy

Scandinavian journal of gastroenterology, 2019-03, Vol.54 (3), p.281-288

2019

Volltextzugriff (PDF)

Biological therapy in inflammatory bowel diseases:Access in Central and Eastern Europe

World journal of gastroenterology : WJG, 2015-02, Vol.21 (6), p.1728-1737

2015

Volltextzugriff (PDF)

Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore

BMC gastroenterology, 2023-02, Vol.23 (1), p.34-34, Article 34

2023

Volltextzugriff (PDF)

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Inflammatory bowel diseases, 2017-11, Vol.23 (11), p.1908-1915

2017

Volltextzugriff (PDF)

Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives

Gastroenterology (New York, N.Y. 1943), 2022-04, Vol.162 (5), p.1512-1524

2022

Volltextzugriff (PDF)

Knotless seton for perianal fistulas: feasibility and effect on perianal disease activity

Scientific reports, 2020-10, Vol.10 (1), p.16693-16693, Article 16693

2020

Volltextzugriff (PDF)

Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case series

Therapeutic advances in gastroenterology, 2024-01, Vol.17, p.17562848241228080-17562848241228080

2024

Volltextzugriff (PDF)

Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1273-1278

2016

Volltextzugriff (PDF)

Author Correction: Knotless seton for perianal fistulas: feasibility and effect on perianal disease activity

Scientific reports, 2021-04, Vol.11 (1), p.8820-8820, Article 8820

2021

Volltextzugriff (PDF)

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

BMC gastroenterology, 2017-08, Vol.17 (1), p.97-97, Article 97

2017

Volltextzugriff (PDF)

Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort Study

Gastroenterology (New York, N.Y. 1943), 2022-12, Vol.163 (6), p.1569-1581

2022

Volltextzugriff (PDF)

Contemporary Imaging Assessment of Strictures and Fibrosis in Crohn Disease, With Focus on Quantitative Biomarkers: From the AJR Special Series on Imaging of Fibrosis

American journal of roentgenology (1976), 2024-04, Vol.222 (4), p.e2329693

2024

Volltextzugriff (PDF)

Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease

Inflammatory bowel diseases, 2014-02, Vol.20 (2), p.251-258

2014

Volltextzugriff (PDF)

Disc‐like lesions in the intestinal tract after renal transplantation

Clinical case reports, 2022-04, Vol.10 (4), p.e05645-n/a

2022

Volltextzugriff (PDF)

Topical Oxymetazoline for Fecal Incontinence in Patients with Spinal Cord Injury: A Double-Blind Randomized Controlled Crossover Study

Diseases of the colon & rectum, 2019-02, Vol.62 (2), p.234

2019

Volltextzugriff (PDF)

Population pharmacokinetics of subcutaneous infliximab CT‐P13 in Crohn’s disease and ulcerative colitis

Alimentary pharmacology & therapeutics, 2021-11, Vol.54 (10), p.1309-1319

2021

Volltextzugriff (PDF)

Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study

Inflammatory bowel diseases, 2022-03, Vol.28 (4), p.495-501

2022

Volltextzugriff (PDF)

Infliximab biosimilar CT-P13 in Crohn's disease

The Lancet (British edition), 2019-04, Vol.393 (10182), p.1671-1672

2019

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(110)

Sprache

Englisch
(110)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

Differential diagnosis of inflammatory bowel disease: imitations and complications

A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease

Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients

Impact of disease location on fecal calprotectin levels in Crohn's disease

High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study

Biosimilars for the Management of Inflammatory Bowel Diseases: Economic Considerations

Relapse rates and predictors for relapse in a real-life cohort of IBD patients after discontinuation of anti-TNF therapy

Biological therapy in inflammatory bowel diseases:Access in Central and Eastern Europe

Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives

Knotless seton for perianal fistulas: feasibility and effect on perianal disease activity

Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case series

Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis

Author Correction: Knotless seton for perianal fistulas: feasibility and effect on perianal disease activity

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

Intestinal Ultrasound Is Accurate to Determine Endoscopic Response and Remission in Patients With Moderate to Severe Ulcerative Colitis: A Longitudinal Prospective Cohort Study

Contemporary Imaging Assessment of Strictures and Fibrosis in Crohn Disease, With Focus on Quantitative Biomarkers: From the AJR Special Series on Imaging of Fibrosis

Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease

Disc‐like lesions in the intestinal tract after renal transplantation

Topical Oxymetazoline for Fecal Incontinence in Patients with Spinal Cord Injury: A Double-Blind Randomized Controlled Crossover Study

Population pharmacokinetics of subcutaneous infliximab CT‐P13 in Crohn’s disease and ulcerative colitis

Multiple Switches From the Originator Infliximab to Biosimilars Is Effective and Safe in Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study

Infliximab biosimilar CT-P13 in Crohn's disease

Suchergebnisse filtern